Article Text

Download PDFPDF
Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy
  1. J Molina-Infante,
  2. B Perez-Gallardo,
  3. G Gonzalez-Garcia,
  4. M Fernandez-Bermejo,
  5. J M Mateos-Rodriguez,
  6. P Robledo-Andres
  1. Unit of Gastroenterology, Hospital San Pedro de Alcantara, Caceres, Spain
  1. Correspondence to:
    Dr J Molina-Infante
    Hospital San Pedro de Alcántara, Avda, Pablo Naranjo s/n, 10003 Caceres, Spain; xavi_molina{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the letter by Krikis et al (Gut 2005;54:171–2). We report on two patients with a poor clinical history (recurrent gastrointestinal haemorrhage, older age, severe comorbidity, anticoagulation, contraindication to β-blockers), successfully treated using only octreotide long-active release (LAR).

A 73-year-old man was admitted six times (32 days of hospital stay) in the previous six months because of recurrent episodes of melaena. Medical history included type 1 diabetes, three myocardial infarctions and multivessel disease treated by triple-bypass graft surgery (left ventricular ejection fraction 35%), ischaemic stroke due to total occlusion of the right carotid artery, surgically solved, and occlusion of the …

View Full Text


  • Competing interests: None.